Literature DB >> 15247616

Resistant Candida parapsilosis associated with long term fluconazole prophylaxis in an animal model.

Bradley A Yoder1, Deanna A Sutton, Vicki Winter, Jacqueline J Coalson.   

Abstract

We report an increased occurrence of fluconazole-resistant Candida parapsilosis after a 4-year period of antifungal prophylaxis in a premature animal neonatal intensive care unit. Although prevention of nosocomial fungal infections in premature infants is desirable, implementation of fluconazole prophylaxis should be undertaken with caution. Where such programs are in place, evaluation of fungal isolates for drug resistance should be considered.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15247616     DOI： 10.1097/01.inf.0000128777.22022.47

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  7 in total

1.  Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit.

Authors:  Emmi Sarvikivi; Outi Lyytikäinen; David R Soll; Claude Pujol; Michael A Pfaller; Malcolm Richardson; Pirkko Koukila-Kähkölä; Päivi Luukkainen; Harri Saxén
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth.

Authors:  Mohan Pammi Venkatesh; Don Pham; Mindy Fein; Lingkun Kong; Leonard E Weisman
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

Review 3.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

Review 4.  Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis.

Authors:  Mohan Pammi; Linda Holland; Geraldine Butler; Attila Gacser; Joseph M Bliss
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

5.  Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection.

Authors:  Brian A McCrossan; Elaine McHenry; Fiona O'Neill; Grace Ong; David G Sweet
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-04-25       Impact factor: 5.747

6.  Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.

Authors:  Jaswinder Kaur Oberoi; Chand Wattal; Neeraj Goel; Reena Raveendran; S Datta; Kamaljeet Prasad
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375

7.  Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study.

Authors:  Juyoung Lee; Han-Suk Kim; Seung Han Shin; Chang Won Choi; Ee-Kyung Kim; Eun Hwa Choi; Beyong Il Kim; Jung-Hwan Choi
Journal:  BMC Pediatr       Date:  2016-05-16       Impact factor: 2.125
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.